Healthy Living/WellnessEuropean Commission Approves Novartis Lung Cancer Drug Zykadia Swiss drug manufacturer Novartis announced that the European Commission has approved Zykadia (ceritinib), a drug used to treat patients suffering from an advanced form of non-small cell lung cancer.by Ted Ranosa
Healthy Living/WellnessResearchers Discover How Lung Cancer Spreads. Possible Clues to Halting Disease Progressionby Dianne Depra
Healthy Living/WellnessLung cancer can go undetected for at least 20 years before it turns deadlyby James Maynard
Leader of Furry Hackers Raided by Feds Months After Attack on Creators of Project 2025, Former Member Claims